ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1988 • ACR Convergence 2023

    Extended-Release versus Immediate-Release Triamcinolone Acetonide for Osteoarthritis of the Knee with Comorbid Diabetes Type 2 Diabetes Mellitus: A Post Hoc Analysis

    Andrew Spitzer1, Helena Rodbard2, Sheikh Usman Iqbal3, Masato Nakazawa3, Mary DiGiorgi3 and Roy Winston3, 1Cedars-Sinai Medical Center, Los Angeles, CA, 2Endocrine and Metabolic Consultants, Rockville, MD, 3Pacira BioSciences, Inc., Tampa, FL

    Background/Purpose: Intraarticular (IA) corticosteroids are generally considered safe and effective to treat osteoarthritis of the knee (OAK) but may cause hyperglycemia that may last for…
  • Abstract Number: 1981 • ACR Convergence 2023

    The Association Between X-ray Progression and Clinical Outcomes in Patients with Hand Osteoarthritis with 5-year Follow-up

    Olga Sleglova1, Jiri Baloun2, Jindriska Gatterova1, Xiao Svec1, Olga Ruzickova1, Karel Pavelka3 and Ladislav Senolt4, 1Rheumatology Institute, Prague, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic, 3Institut of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Praha, Czech Republic, 4Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Praha, Czech Republic

    Background/Purpose: Hand osteoarthritis (HOA) is a heterogeneous disorder with two main subtypes, non-erosive and erosive. The progression of HOA is assessed by various radiographic scoring…
  • Abstract Number: 1928 • ACR Convergence 2023

    Response to Sars-Cov2 Vaccination in Rheumatic and Neurological Patients Treated with Different Immunosuppressive Therapies

    Cristina Calomarde Gomez1, Raquel Ugena García1, Julia Valera2, Melisa Mena2, Maria Esteve2, Irma Casas2, jose Antonio Dominguez-Benitez2, lidia Carabias-Ane2, isaac Nuño-Ruiz2, Cristina ramo-Tello2, Javier Santesmases2, Lourdes Mateo Soria3 and Melania Martinez Morillo1, 1Rheumatology department. Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 2Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 3HOSPITAL GERMANS TRIAS I PUJOL, Badalona, Spain

    Background/Purpose: Vaccination against SARS-CoV2 has been the primary global strategy to prevent severe forms of this respiratory infection. However, multiple studies have shown that patients…
  • Abstract Number: 1991 • ACR Convergence 2023

    Therapeutic Efficacy of Intra Articular Injection of Human Bone Marrow Derived Mesenchymal Stem Cells in Knee Osteoarthritis; Randomized, Double-blind, Placebo-controlled Clinical Trial

    Ji Won Yang, Bong-Woo Lee, Jennifer Lee and Ji Hyeon Ju, Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea

    Background/Purpose: Osteoarthritis (OA) is severe and intractable musculoskeletal disease that eventually leads to joint failure and pain due to inflammation and joint injury. Mesenchymal stem…
  • Abstract Number: 1921 • ACR Convergence 2023

    Clinical Spectrum of VEXAS Syndrome in a Rheumatology Department

    Herman Mann1, Blanka Stiburkova2, Katerina Pavelcova1, Monika Belickova3, Cyril Salek3, Jana Juhaszova1 and Jiri Vencovsky4, 1Institute of Rheumatology, Praha 2, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic, 3Institute of Hematology and Blood Transfusion, Praha 2, Czech Republic, 4Institute of Rheumatology, Prague, Czech Republic, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

    Background/Purpose: VEXAS (vacuoles, E1 activating enzyme, X-linked, auto-inflammatory, somatic) syndrome is a clinically serious and potentially fatal adult-onset disease caused by somatic mutations in the…
  • Abstract Number: 1937 • ACR Convergence 2023

    Efficacy of Different Treatment Approaches for Cardiac Sarcoidosis

    Frank Cai1, Anisha Paulson1, Amy Wozniak2, Emily Gilbert2 and Rochella Ostrowski2, 1Loyola University Medical Center, Oak Park, IL, 2Loyola University Medical Center, Maywood, IL

    Background/Purpose: There is currently a lack of a consensus standardized guideline for the treatment of cardiac sarcoidosis (CS) because of its rarity, heterogeneity of disease…
  • Abstract Number: 1919 • ACR Convergence 2023

    Arthroplasty Outcomes in Immune Checkpoint Inhibitor-Treated Patients: A Single Center Series

    Yasmine Elfarra1, Edward DiCarlo2, Jonathan Vigdorchik2, Carlos Aude3, Nilasha Ghosh3, Anne Bass3 and Karmela Kim Chan2, 1Weill Cornell, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Immune checkpoint inhibitors (ICI) have changed the landscape of cancer treatment dramatically, but because of their mechanism of action they are also known to…
  • Abstract Number: 1153 • ACR Convergence 2023

    Unmasking SAPHO: A Case Series Revealing the Clinical Spectrum and Treatment Approaches

    Manush Sondhi1, Warda Maqsood2 and Sarwat Umer3, 1Louisiana State University, Shreveport, LA, 2LSU Health Science Center, Shreveport, LA, 3LSU Health Shreveport, Shreveport, LA

    Background/Purpose: SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) is a relatively rare and often underdiagnosed inflammatory disorder. Its diagnosis can be challenging due to its…
  • Abstract Number: 1664 • ACR Convergence 2023

    Fibroblast Specific Interferon Regulatory Factor 7 (IRF7) Expression Is a Key Link Between Type I Interferon Activation and the Exaggerated Dermal and Pulmonary Fibrosis in Systemic Sclerosis

    Minghua Wu1, Jerry Alonso2, Julio charles2, Brian Skaug2, Tingting Mills3, Maureen Mayes2 and Shervin Assassi4, 1Department of Internal Medicine, Division of Rheumatology, The University of Texas Health Science Center at Houston, Houston, TX, 2Division of Rheumatology, University of Texas McGovern Medical School, Houston, TX, 3Biochemistry Department, University of Texas McGovern Medical School, Houston, TX, 4University of Texas McGovern Medical School at Houston, Houston, TX

    Background/Purpose: A prominent interferon (IFN) activation signature has been observed at the peripheral blood and end-organ levels in systemic sclerosis (SSc). However, the mechanisms by…
  • Abstract Number: 1182 • ACR Convergence 2023

    Treatment Trajectories and Patient Outcomes in Idiopathic Inflammatory Myopathies

    Kristin Wipfler1, Michael Feely2, Gulsen Ozen3, Urbano Sbarigia4, Federico Zazzetti5, Anna Sheahan6, Iris Lin7, Evo Alemao8 and Kaleb Michaud2, 1FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 2University of Nebraska Medical Center, Omaha, NE, 3University of Nebraska Medical Center, Bellevue, NE, 4Janssen Pharmaceutica, Beerse, Belgium, 5Janssen Research & Development, LLC, Spring House, PA, 6Janssen, Raleigh, NC, 7Janssen, Horsham, PA, 8Janssen Pharmaceuticals, New Hope, PA

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are rare, heterogeneous diseases characterized by chronic skeletal muscle inflammation and weakness. Initial conventional therapy is based on expert opinion…
  • Abstract Number: 1930 • ACR Convergence 2023

    Blue Digit Syndrome as the Initial Presentation of Various Diseases: A Case Series

    Raquel Ugena García1, Juan José Lluch Galcerá2, Cristina Calomarde Gomez1, Ivette Casafont-Sole3 and Lourdes Mateo Soria2, 1Rheumatology department. Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 2Hospital Germans Trias i Pujol, Badalona, Spain, 3Hospital Universitari Germans Trias i Pujol, Badalona, Spain

    Background/Purpose: Blue Digit Syndrome (BDS) represents the cutaneous manifestation of numerous diseases that cause blue discoloration in one or more fingers in the absence of…
  • Abstract Number: 1170 • ACR Convergence 2023

    Damage Accrual in Idiopathic Inflammatory Myopathies: Data from a Monocentric Cohort and Impact on Patients’ Quality of Life

    Chiara Cardelli1, Simone Barsotti2, Elenia Laurino1, Michele Diomedi1, Federico Fattorini1, Alessandra Tripoli1, Linda Carli1 and Marta Mosca1, 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 2Internal Medicine, Ospedale di Livorno, Pisa, Italy

    Background/Purpose: Although the prognosis of Idiopathic Inflammatory Myopathies (IIMs) has noticeably improved over time, their chronicity may still expose a considerable number of patients to…
  • Abstract Number: 1179 • ACR Convergence 2023

    Rituximab in the Treatment of Interstitial Lung Disease Associated with the Antisynthetase Syndrome

    Javier Narvaez1, Elena Cañadillas-Sanchez2, Ivan Castellvi3, Juan José Alegre4, Paola Vidal-Montal5 and Joan Miquel Nolla5, 1Hospital Universitario de Bellvitge, Barcelona, Spain, 2Department of Rheumatology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 3Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau, Sant Just Desvern, Spain, 4Department of Rheumatology, Hospital Universitario Dr Peset, Valencia, Spain, 5Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain

    Background/Purpose: To assess the real-world, long-term effectiveness of rituximab (RTX) as a rescue therapy in patients with antisynthetase syndrome and interstitial lung disease (ASS-ILD). Methods:…
  • Abstract Number: 1673 • ACR Convergence 2023

    Immunomodulatory Treatment and Autoimmune Patient Responses to COVID-19 Booster Shots: Results from the Covid-19 VaccinE Response in Rheumatology Patients (COVER) Study

    Amy S. Mudano1, Gary Cutter2, Ted R Mikuls3, Geoffrey Thiele4, Emily Holladay2, Kevin Withrop5, Mark Law4, Bart Hamilton4, Monique Bastidas6, Michael Zikry6, Kelly Chun6, Michael George7 and Jeffrey Curtis2, 1Illumination Health, Hoover, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3Division of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE, 4University of Nebraska Medical Center, Omaha, NE, 5Oregon Health & Science University, Schools of Medicine and Public Health,, Portland, OR, 6Labcorp, Calabasas, CA, 7University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Given an increased risk of COVID-19 in patients with autoimmune conditions, we must better understand the immunogenicity and safety of SARS-CoV-2 vaccines in people…
  • Abstract Number: 1932 • ACR Convergence 2023

    The Association Between Initial Ferritin and Complications from Adults Onset Stills Disease and Intensive Care Unit Admission

    Olivia Yang1, Caroline Bui1, Scott Kubomoto1, Napatkamon Ayutyanont1, Kimberly Vickery1 and Kumar Venkat2, 1Riverside Community Hospital, Riverside, CA, 2Retired, Irvine, CA

    Background/Purpose: Adult Onset Still's Disease (AOSD) is an autoinflammatory disease characterized by quotidian fever, arthralgia, and a salmon colored rash. Due to its rarity, there…
  • « Previous Page
  • 1
  • …
  • 294
  • 295
  • 296
  • 297
  • 298
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology